Latest Breaking News On - Todd kehrli - Page 7 : comparemela.com

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that in parallel with the growing adoption of ProSense®, the number of independent, non-sponsored studies of its cryoablation system has significantly increased. In addition to the 12 studies already published in peer reviewed journals and presented in scienti

United statesMichael polyviouTodd kehrliEyal shamirIcecure medical ltdCompany annual report on formCure medicalPrivate securities litigation reform actMiddle eastRisk factorsAnnual reportIcecure medical ltdBreast cancerCosmetic resultsMusculoskeletal systemTumor removal